Coronavirus Update: Gilead Ready To Unveil Remdesivir Price

Plus Developments From Vir and Eli Lilly

20 May 2020

• By Scrip Team

Gilead is preparing to unveil its long-term commercial plan for the antiviral therapy, including its expectations on prices and profits.

gilead — Gilead's remdesivir has gained emergency use approval in the US and similar status in Japan, with the EU expected to issue a conditional marketing approval shortly

More from COVID-19

More from Scrip